AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.NIH Grantees Sharpen Understanding of Antibodies That May Cut Risk of HIV Infection
“What immune response should a vaccine elicit to prevent HIV infection? Two studies published online today [March 19, 2014] bring scientists closer to answering this question by identifying previously unrecognized attributes of antibodies that appear to have reduced the risk of HIV infection in the only clinical trial to show efficacy, albeit modest, of an experimental vaccine regimen in people.
“Earlier analyses of the results of that trial, known as RV144, suggested that antibodies to sites within a part of the HIV envelope called V1V2 correlated with reduced risk of HIV infection. These antibodies belong t...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - March 28, 2014 Category: Infectious Diseases Source Type: news
Updated HHS Perinatal Antiretroviral Treatment Guidelines Released
The HHS Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission announces the release of the updated Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States.
For a complete preview of key updates to the guidelines, please see What's New in the Guidelines. Additions and revisions are also highlighted in yellow throughout the text and tables of the guidelines.
To view or download the guidelines, go to the Perinatal Guidelines section of AIDSinfo. Separate PDF files of t...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - March 28, 2014 Category: Infectious Diseases Source Type: news
Recent HIV/AIDS News from NIAID
March 5, 2014: Genetic Modification of Cells Proves Generally Safe as HIV Treatment Strategy
“Scientists today report initial results from humans on the safety and tolerability of a novel strategy to curb HIV disease by removing key cells from HIV-infected individuals, genetically modifying the cells to resist HIV infection and returning them to those individuals. The basic and pre-clinical research on this strategy, which eventually might help people control the virus without drugs, was funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.&rd...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - March 14, 2014 Category: Infectious Diseases Source Type: news
March 20 is National Native HIV/AIDS Awareness Day
—an annual observance that highlights the impact of HIV/AIDS on American Indian, Alaska Native, and Native Hawaiian communities.
According to the Centers for Disease Control and Prevention (CDC), approximately 20% of HIV-infected people in the United States do not know that they are infected; however, among American Indians and Alaska Natives the figure is closer to 25%. Compared to members of other ethnic or racial groups, American Indians and Alaska Natives who receive a diagnosis of HIV infection or AIDS have one of the shortest survival times. This may be due to HIV infections diagnosed late in the course of the...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - March 14, 2014 Category: Infectious Diseases Source Type: news
Recent HIV/AIDS News from NIAID and NIH
February 25, 2014: NIH Expands Focus of Research Funding Opportunity Targeting HIV Reservoirs
“The National Institute of Allergy and Infectious Diseases (NIAID) and the National Institute of Mental Health, both part of the National Institutes of Health, recently expanded the scientific scope of an HIV-cure related funding announcement to allow for a broader range of studies and approaches.
“Specifically, the funding opportunity 'Targeting Persistent HIV Reservoirs,' which was originally issued February 17, 2012, has been significantly expanded to allow for 'proposed basic research into the cel...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - February 28, 2014 Category: Infectious Diseases Source Type: news
March 10 is National Women and Girls HIV/AIDS Awareness Day
Each year, March 10 is set aside to observe National Women and Girls HIV/AIDS Awareness Day. The purpose of this day is to recognize the impact of HIV on women and girls and encourage action to reduce the burden of HIV/AIDS among women and girls. According to the Centers for Disease Control and Prevention (CDC), at the end of 2010, 1 in 4 people living with a diagnosis of HIV infection in the United States were women.
Explore our National Women and Girls HIV/AIDS Awareness Day webpage [en español] to learn more about the annual observance and to find HIV/AIDS-related information specific to women and girls. ...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - February 28, 2014 Category: Infectious Diseases Source Type: news
Recent HIV/AIDS News from FDA and NIAID
News from FDA
February 3, 2014: Approval of Generic Version of Lamivudine and Zidovudine Tablets, 150 mg/300 mg
For more information, view the AIDSinfo patient fact sheet on Combivir.
News from NIAID
February 11, 2014: NIH-Funded Researchers Use Antibody Treatment to Protect Humanized Mice from HIV
February 5, 2014: Durable End to AIDS Will Require HIV Vaccine Development
February 5, 2014: NIH Seeks Public-Private Proposals for HIV Cure Research: 5-Year Awards Could Total Up to $56 Million
February 3, 2014: NIH Scientists Find Mechanism That Helps HIV Evade A...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - February 12, 2014 Category: Infectious Diseases Source Type: news
infoSIDA Featured on the “Bienvenidos a América” Radio Show
infoSIDA, the Spanish-language companion website to AIDSinfo, is featured on the “Bienvenidos a América” radio program. This radio show is designed to introduce infoSIDA to a national audience, with a focus on new immigrants to the United States. The show is produced by Hispanic Communications Network and can be heard on radio stations across the United States. Check your local stations for times or listen online.
infoSIDA provides Spanish-language HIV/AIDS resources to the Hispanic/Latino community in an easy-to-use format, while utilizing culturally appropriate and relevant language. The infoSIDA full...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - February 12, 2014 Category: Infectious Diseases Source Type: news
Updated HHS Pediatric Antiretroviral Treatment Guidelines Released
The HHS Panel on Antiretroviral Therapy and Medical Management of HIV-Infected Children announces the release of the updated Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection.
For a complete preview of key updates to the guidelines, please see What's New in the Guidelines. Additions and revisions are also highlighted in yellow throughout the text and tables of the guidelines.
To view or download the guidelines, go to the Pediatric Guidelines section of AIDSinfo. Separate PDF files of the tables or recommendations can also be downloaded from the page.
Your Feedback Is Welcome
Feedback on the l...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - February 12, 2014 Category: Infectious Diseases Source Type: news
NIH Research Network Finds Many Youth Have High Levels of HIV
“More than 30 percent of young males who had sex with other males and who were subsequently enrolled in a government treatment and research network were found to have high levels of HIV, reported researchers from the National Institutes of Health and other institutions.
“The health status of the study participants, who ranged in age from 12 to 24 years, was monitored as part of their participation in the Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN). The ATN provides medical care to youth with HIV and offers counseling and, medications, and other preventive measures to youth who are ...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - January 31, 2014 Category: Infectious Diseases Source Type: news
February 7 is National Black HIV/AIDS Awareness Day
National Black HIV/AIDS Awareness Day serves to raise awareness of the disproportionate burden of HIV/AIDS among African Americans. According to the Centers for Disease Control and Prevention (CDC), blacks represent approximately 12% of the U.S. population, but accounted for an estimated 44% of new HIV infections in 2010.
Explore our National Black HIV/AIDS Awareness Day webpage [en español] to learn more about the annual observance and to find HIV-related information specific to African Americans. (Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - January 31, 2014 Category: Infectious Diseases Source Type: news
Study Examines the Effect of 24 Weeks of Statin Therapy on Systemic and Vascular Inflammation in HIV-Infected Participants on ART
“HIV-infected individuals are at increased cardiovascular disease (CVD) risk due in part to inflammation. Statins decrease inflammation in the general population, but their effect in HIV is largely unknown. … This is an on-going randomized, double-blinded, placebo-controlled trial to evaluate the effect of statins on inflammatory markers in HIV. Subjects received rosuvastatin 10 mg daily or placebo for 24 weeks. Subjects were receiving stable antiretroviral therapy with low-density lipoprotein (LDL)-cholesterol ≤130 mg/dL and evidence of heightened immune activation or inflammation. … 147 were enroll...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - January 17, 2014 Category: Infectious Diseases Source Type: news
Study Demonstrates NIH-Created Toxin Can Kill HIV-Infected Cells That Persist Despite Treatment
“A team including University of North Carolina and NIH scientists has demonstrated in a mouse model that an HIV-specific poison can kill cells in which the virus is actively reproducing despite antiretroviral therapy. According to the researchers, such a targeted poison could complement antiretroviral therapy, which dramatically reduces the replication of HIV in infected cells but does not eliminate them. …
“The immunotoxin, known as 3B3-PE38, was created in 1998 in the laboratories of Edward A. Berger, Ph.D., of the National Institute of Allergy and Infectious Diseases, and Ira Pastan, Ph.D., of the Nat...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - January 17, 2014 Category: Infectious Diseases Source Type: news
AIDSinfo Mobile Guidelines Development: Reaching HIV Practitioners at the Point of Care
Exhibits on display at the recent 5th annual mHealth Summit included a poster tracing AIDSinfo’s ongoing efforts to develop mobile HIV/AIDS medical practice guidelines. The poster depicts how AIDSinfo is responding to rapid advances in technology to meet the increasing expectation for access to HIV-related information at the point of care (i.e., via tablets and smartphones). AIDSinfo mobile guidelines development is propelled by a 10-fold increase in mobile traffic to AIDSinfo over the past 3 years, as well as research that shows that 90% of health care providers surveyed on the AIDSinfo website have Internet access ...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - January 3, 2014 Category: Infectious Diseases Source Type: news
FDA Approves Oral Suspension Form of Raltegravir
“On December 20, 2013, FDA approved a new dosage form, ISENTRESS® (raltegravir) for oral suspension, in combination with other antiretroviral agents for the treatment of HIV-1 infection in pediatric patients 4 weeks of age and older, weighing at least 3 kg to less than 20 kg. This also includes a new Instructions for Use document as part of the patient labeling.”
The updated labeling will be available at the FDA website.
More information is available:
FDA: Press release (Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Departmen...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - January 3, 2014 Category: Infectious Diseases Source Type: news
